ObjectiveTo observe the difference of circulating tumor cells (CTC) in peripheral blood of patients with different degrees of cervical lesions, and to evaluate the effectiveness of CTC detection in screening early invasive cervical cancer.MethodsFrom December 2015 to October 2017, 63 cases of cervicitis, low-grade and high-grade intraepithelial lesions (LSIL, HSIL) and early invasive cervical cancer were confirmed by histopathological and clinical stages in Zhongshan Boai Hospital and Zhongshan Hospital Affiliated to Zhongshan University. The immunomagnetic bead negative enrichment technique combined with immunofluorescence was used.In situhybridization (imFISH) was used to detect CTC in peripheral blood of patients. The positive rate and quantity of CTC in four groups were analyzed. The diagnostic efficacy of CTC in early invasive cervical cancer was evaluated based on the results of histopathological diagnosis and clinical staging.Results①The positive rates of CTC in cervicitis group, LSIL group, HSIL group and early invasive cervical cancer group were 0, 0, 19.05% and 84.13% respectively. The overall difference was statistically significant (χ2=504.00,P<0 .05). the positive rate of ctc in early invasive cervical cancer group was higher than that in other groups (P<0 .008 3). the positive rates of ctc in hsil group were significantly different from those in lsil group and cervicitis group (P<0 .008 3). ②the average number (median) of ctc positive in cervicitis group, lsil group, hsil group and early invasive cervical cancer group was 0, 0, 1/4 ml, 3/4 ml, respectively. the average number of positive ctc in early invasive cervical cancer group was higher than that in other groups, and the difference was significant compared with other groups (P<0 .008 3). the average number of ctc positive in hsil group was significantly different from that in lsil and cervicitis group (P<0 .008 3). ③the sensitivity, specificity, coincidence rate, positive predictive value and negative predictive value of ctc positive results in the diagnosis of early invasive cervical cancer were 84.13%, 93.65%, 91.27%, 81.54% and 94.65%, respectively.ConclusionCTC exists in patients with HSIL and early invasive cervical cancer. With the aggravation of cervical lesions, the positive rate and number of CTC test results increase. CTC detection in early invasive cervical cancer screening has a certain practical value in clinic.
